Showing results (381-390 of 499) with videos related to
Sort By:
Pageof 50
The Journal of Clinical Investigation|April 25, 2024
Type 2 cannabinoid receptor expression on microglial cells regulates neuroinflammation during graft-versus-host diseaseAlison Moe, Aditya Rayasam, Garrett Sauber, et al.The Journal of Experimental Medicine|August 10, 2016
Inflammatory monocytes and NK cells play a crucial role in DNAM-1-dependent control of cytomegalovirus infectionTihana Lenac Rovis, Paola Kucan Brlic, Noa Kaynan, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 19, 2022
High-Fat Diet Rapidly Modifies Trafficking, Phenotype, and Function of Plasmacytoid Dendritic Cells in Adipose TissueSusanne Stutte, Hellen Ishikawa-Ankerhold, Lydia Lynch, et al.The Journal of Experimental Medicine|February 4, 2010
Type I IFN controls chikungunya virus via its action on nonhematopoietic cellsClémentine Schilte, Thérèse Couderc, Fabrice Chretien, et al.Plos One|April 14, 2022
Dysregulation of the leukocyte signaling landscape during acute COVID-19Isaiah R Turnbull, Anja Fuchs, Kenneth E Remy, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Myofibroblastic CAFs arising from bone-resident osteoblast precursors retain an osteolineage signature and support breast cancer progression via Osterix-mediated signalingGiulia Furesi, Carisa Zeng, Emily M Eul, et al.Biorxiv : the Preprint Server for Biology|December 18, 2023
An inducible genetic tool for tracking and manipulating specific microglial states in development and diseaseKia M Barclay, Nora Abduljawad, Zuolin Cheng, et al.Elife|August 9, 2019
Toxoplasma gondii infection drives conversion of NK cells into ILC1-like cellsEugene Park, Swapneel Patel, Qiuling Wang, et al.Neuron|July 15, 2019
TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's DiseaseAna Griciuc, Shaun Patel, Anthony N Federico, et al.Proceedings of the National Academy of Sciences of the United States of America|July 11, 2003
Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-GMitsunori Shiroishi, Kouhei Tsumoto, Kimie Amano, et al.Pageof 50